Tag: Onxeo
Onxeo soon to be delisted from the Nasdaq
The last trading day is November 8. Onxeo soon to be delisted from the Nasdaq | Photo credit: Shutterstock As announced on August 17, 2022, Onxeo will soon no longer…
Onxeo: Danish shares delisted in November – 08/31/2022 at 12:17
(CercleFinance.com) – Onxeo announced on Wednesday that it had received approval from the Nasdaq in Copenhagen for its Danish shares to be withdrawn from trading on the Nasdaq First North…
Onxeo shareholders approve the withdrawal from the Nasdaq First North market in Copenhagen – 08/17/2022 at 20:00
Company to submit delisting request to Nasdaq Paris (France), August 17, 2022 – 8:00 p.m. CEST – Onxeo SA (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereinafter “Onxeo”…
Onxeo: green light from AG to withdraw from Nasdaq First North
(CercleFinance.com) – Onxeo announces that its Combined General Meeting has adopted all the resolutions presented by its Board of Directors, including the withdrawal of the shares from listing on the…
Onxeo: green light from shareholders for the withdrawal from the Nasdaq First North market in Copenhagen – 08/18/2022 at 08:07
(AOF) – Onxeo shareholders have approved the withdrawal from the Nasdaq First North market in Copenhagen. They conferred full powers on the Board of Directors to carry out this operation.…
Onxeo: AG green light to withdraw from Nasdaq First North – 08/18/2022 at 08:15
(CercleFinance.com) – Onxeo announces that its Combined General Meeting has adopted all the resolutions presented by its Board of Directors, including the withdrawal of the shares from listing on the…
Onxeo withdraws from the Nasdaq First North market in Copenhagen
By Alexandra Saintpierre Published on 08/17/2022 at 8:26 p.m. Photo credit © *ONXEO …
Onxeo presents its 2021 financial results and announces new financing of 12 million euros – 04/06/2022 at 18:00
Cash of €17.9 million as of December 31, 2021 New financing subscribed by the historical shareholders Invus and Financière de la Montagne, in the amount of 12 million euros, in…
Onxeo: new preclinical data on AsiDNA
(CercleFinance.com) – Onxep rose by more than 4% on the stock market on Wednesday after the publication of data confirming the relevance of the association of its compound AsiDNA with…
Onxeo: 2022 financial calendar – 01/13/2022 at 6:00 p.m.
Paris (France), January 13, 2022 – 6 p.m. CET – Onxeo SA (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereinafter “Onxeo” or “the Company”, a clinical-stage biotechnology company…
Onxeo: Julien Miara is appointed Interim Chief Executive Officer
Through Alexandra Saintpierre Posted on 01/03/2022 at 8:50 p.m. Photo credit © * ONXEO (Boursier.com) – Onxeo SA has appointed Julien Miara as Interim Managing Director, as of January 3,…
Onxeo: new interim CEO
(CercleFinance.com) – Onxeo announces the appointment of Julien Miara as interim CEO, as of January 3, 2022, following the decision of the board of directors, which is also actively working…